The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
about
Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidenceAgeing, growth hormone and physical performance.Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study.Osteosarcoma and acromegaly: a case report and review of the literature.Investigational anabolic therapies for osteoporosis.The development of composite circulating biomarker models for use in anticancer drug clinical development.Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients.Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women.Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects.The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults.Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.Serum insulin-like growth factor 1 in the aging horse.Problems with GH doping in sports.Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.[Usefulness of subcutaneous or long-acting octreotide as a predictive test and in the treatment of acromegaly].Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort.Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.Exponentially growing osteosarcoma of mandible with acromegaly.Growth hormone secretion and sensitivity in men with idiopathic osteoporosis.Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age.Serum insulin-like growth factor-I and breast cancer.Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.Acromegaly and end-stage renal disease: a diagnostic challenge.Hematologic neoplasias and acromegaly.Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.Impaired postprandial response of the insulin-like growth factor system in maintenance haemodialysis.Body mass index, waist circumference and waist–hip ratio and serum levels of IGF-I and IGFBP-3 in European womenDivergent Effects of Short-Term, Very-Low-Calorie Diet on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 Serum Concentrations in Premenopausal Women with ObesityParadoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides
P2860
Q35099084-39A96592-3E1B-4F0B-B0A3-323B63F979CAQ35667556-DB414253-2A75-4AFA-AD5A-4F48BAE9982DQ35872930-25426F21-3382-4D96-B8D7-C94539F6892DQ35953962-502DA144-AFBA-4E6A-B428-36FAA38CDFC6Q36295508-830B0FB4-411B-46EF-B165-AB13EE014F7AQ36720803-6FF358B1-4C7E-42A1-85C4-8085BD17C037Q37772520-1051ECF3-37FD-4458-8345-2A3990A6430FQ39863702-C56F440C-1445-4BEA-BBBE-299E2051F2DFQ40217287-B3C0A6CD-121B-4E20-A97E-3D6F14A09F57Q42489034-CA2B6B95-ABAC-4DF8-A081-A826379BD102Q43835711-F2DB78F4-4D29-4A04-84CD-78C19A98BA24Q43892885-4702DF12-3EB8-45B1-A470-B6DF229538ECQ44118715-EB6A1DF9-B1CF-4168-9FB9-E51DCBC76EF7Q44514751-0A5198AB-5518-4AFB-A2FC-4085FA9E686EQ44625241-F4FC5FFD-86CC-45D0-AA5F-8A7B94985582Q44764934-DFCAA234-C9A6-4753-B926-E080985FF042Q44911949-78DE6A13-B1FD-45FA-9A17-1AF66EBC5225Q45217376-14F4CAB7-B557-4D58-83D1-715556D572AAQ46113118-DE397078-3DC5-42B3-A0DE-A8071E14F38AQ46857844-F47514E7-1270-4EE5-AFCC-4368D757D880Q47833573-9E4E417E-95FA-4B72-803D-AC70B94B8E3AQ47926805-840CA81D-EE5D-4FBD-9D80-03CA2D013DFEQ48905813-6965D386-9560-4106-B04C-EB9D969ED8C0Q48910664-8FB3DB51-F209-4542-B949-D518F840B17AQ51396451-19B6E6BD-A2AE-4AA7-AA77-49756C6F9372Q51552786-A9B9F7A4-8AF3-4160-AC78-D90184B92213Q51562466-BC9C848C-2F49-4C11-8401-4AE8AB4A8D31Q51781158-CC325EFA-AE80-4807-84F3-C15EF0B70522Q53403062-7FB565B5-D385-4426-9BA7-2F6DEE737548Q53407314-53438E56-7C94-40BD-B445-D86EE667207FQ54731657-21DD4876-AD75-4FDA-9FB1-FAA46F1312CDQ57054412-05069A2E-EF85-4F3F-A402-960EE9AC06CFQ58457135-E95147AC-1F15-46C1-A618-1B528C2ACC00Q58887077-4ED98B84-0148-46E5-9ACB-1D11AA0AEDE1
P2860
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
description
scientific article published on 01 July 1994
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1994
@uk
name
The ratio between serum levels ...... reased in acromegalic patients
@en
The ratio between serum levels ...... reased in acromegalic patients
@nl
type
label
The ratio between serum levels ...... reased in acromegalic patients
@en
The ratio between serum levels ...... reased in acromegalic patients
@nl
prefLabel
The ratio between serum levels ...... reased in acromegalic patients
@en
The ratio between serum levels ...... reased in acromegalic patients
@nl
P2093
P2860
P50
P1476
The ratio between serum levels ...... reased in acromegalic patients
@en
P2093
P2860
P356
10.1111/J.1365-2265.1994.TB03788.X
P577
1994-07-01T00:00:00Z